U.S. Women's Telehealth Giant Outlines Plan to Expand Into Fertility and Menopause Care

Industry Pulse News Desk · 2026-09-15

Chief Executive Keira Krausz announced strategic plans to broaden clinical offerings to include fertility support, menopause management, and diagnostic testing.

The largest women's telehealth provider in the United States is preparing to broaden its clinical scope into fertility care, menopause management, and advanced diagnostics. The strategic shift aims to transition the platform from specialized care into a comprehensive healthcare provider for women across multiple life stages.

Chief Executive Officer Keira Krausz detailed the expansion strategy, emphasizing a multi-decade approach to patient care. Under the initiative, the company will introduce specialized virtual consultation services, integrated lab testing, and targeted treatment plans designed to address hormonal health and reproductive medicine.

Diagnostic integration will serve as a key component of the updated platform. Patients will gain access to at-home testing kits and coordinated laboratory services, allowing clinicians to monitor metabolic, endocrine, and reproductive markers before recommending personalized therapeutic interventions.

The move represents a significant enlargement of the company's service portfolio, which previously focused on specialized reproductive and primary health needs. By incorporating midlife care and diagnostic tools, the platform intends to extend patient retention over several decades.

Rollout of the new services will occur in phases over the coming quarters, with diagnostic testing and menopause programs slated for initial release. Further details regarding pricing structures and insurance coverage integrations are expected to be announced prior to launch.